1. "2014"
Formats
  1. Journal Article (2603)
  2. Meeting Abstract (1417)
  3. Book Section (235)
  4. Conference Paper (23)
  5. Book Whole (16)
  6. Review (3)
Groups
  1. Department of Medicine (1584)
  2. GSK Faculty (1082)
  3. Surgery (895)
  4. Solid Tumor Oncology Division (840)
  5. Center for Hematologic Malignancies (703)
  6. Sloan Kettering Institute Faculty (672)

More Groups

People
  1. Jedd Wolchok (71)
  2. Sergio Giralt (71)
  3. Ross Levine (69)
  4. Martin Tallman (62)
  5. Michael Berger (59)
  6. Mithat Gonen (55)

More People

Years
  1. 2014 (4297)
Publications
  1. Journal of Clinical Oncology (420)
  2. Blood (228)
  3. International Journal of Radiation Oncology, Biology, Physics (131)
  4. Cancer Research (104)
  5. Modern Pathology (89)
  6. Laboratory Investigation (82)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (446)
  3. Springer (318)
  4. Elsevier Science, Inc. (246)
  5. Nature Publishing Group (242)
  6. American Society of Hematology (230)

More Publishers

Results (4297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475
    Meeting Abstract

    Joseph, R. W.; Elassaiss-Schaap, J.; Wolchok, J. D.; Joshua, A. M.; Ribas, A.; Hodi, F. S.; Hamid, M.; Robert, C.; Daud, A.; Hwu, W. J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Jones, L.; Liu, Q.; Armstrong, G. T.; Ness, K. K.; Yasui, Y.; Devine, K.; Tonorezos, E.; Soares-Miranda, L.; Sklar, C. A.; Douglas, P. S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Genome-wide association study (GWAS) of efficacy and safety endpoints in pazopanib- or sunitinib-treated patients with renal cell carcinoma (RCC)
    Meeting Abstract

    Johnson, T.; Xu, C. F.; Choueiri, T. K.; Figlin, R. A.; Sternberg, C. N.; King, K. S.; Xue, Z. Y.; Stinnett, S.; Deen, K. C.; Carpenter, C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Ipilimumab in acral melanoma: A retrospective review
    Meeting Abstract

    Johnson, D. B.; Peng, C.; Abramson, R. G.; Wolchok, J. D.; Sosman, J. A.; Carvajal, R. D.; Ariyan, C. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Patient-derived xenografts as models for the identification of predictive biomarkers in esophagogastric cancer
    Meeting Abstract

    Janjigian, Y. Y.; Vakiani, E.; Imtiaz, T.; Huang, X.; Ilson, D. H.; Rizk, N. P.; Coit, D. G.; Strong, V. E.; de Stanchina, E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Prechemotherapy cognitive function in 362 breast cancer (BC) patients and 362 age-paired controls without cancer: A nationwide longitudinal trial conducted through the University of Rochester Cancer Center (URCC) Community Clinical Oncology Program (CCOP) Research Base (RB)
    Meeting Abstract

    Janelsins, M. C.; Heckler, C. E.; Mustian, K. M.; Ontko, M.; Hopkins, J. O.; Weiss, M.; Corso, S. W.; Peppone, L. J.; Palesh, O.; Tejani, M. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Identification of biomarkers to predict response to single-agent platinum chemotherapy in metastatic triple-negative breast cancer (mTNBC): Correlative studies from TBCRC009
    Meeting Abstract

    Isakoff, S. J.; He, L.; Mayer, E. L.; Goss, P. E.; Traina, T. A.; Carey, L. A.; Krag, K.; Liu, M. C.; Rugo, H. S.; Stearns, V.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase I study of the single-agent CDK4/6 inhibitor LEE011 in pts with advanced solid tumors and lymphomas
    Meeting Abstract

    Infante, J. R.; Shapiro, G.; Witteveen, P.; Gerecitano, J. F.; Ribrag, V.; Chugh, R.; Issa, I.; Chakraborty, A.; Matano, A.; Zhao, X. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of anti-HER3 monoclonal antibody LJM716 in combination with trastuzumab in patients with HER2-overexpressing metastatic breast or gastric cancer
    Meeting Abstract

    Im, S. A.; Juric, D.; Baselga, J.; Kong, A.; Martin, P.; Lin, C. C.; Dees, E. C.; Schellens, J. H. M.; De Braud, F. G.; Delgado, L.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save